About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT01367561

Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function

This is a double-blind, randomized, study at a single clinical site investigating the effect of methylnaltrexone and naloxone versus placebo in healthy males who have received a short-acting opioid, r...

Lead sponsor: Bausch Health Americas, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bausch Health Americas, Inc.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Healthy males, 18 to 65 yrs with normal urinary function
•2. Body weight less than 150 kg and Body Mass Index between 20-32.

Exclusion Criteria

•1. Females
•2. History of drug or alcohol abuse
•3. History of significant chronic illness (cardiovascular, gastrointestinal, pulmonary, neurologic, endocrine, renal, hepatic, etc.)
•4. Subjects who received opioids for one week or longer in the last 2 months.

Related studies

COMPLETEDPhase 1/2

A Study to Evaluate Metabolism, Excretion, and Mass Balance of [14C]Vapendavir

NCT06834295 · Healthy Males

Beetroot Extract and Its Influence on Cardiovascular and Autonomic Recovery From the Effort in Healthy Males

NCT05294198 · Healthy Males

Effect of a 4-week Post-exercise Sauna Bathing on Targeted Gut Microbiota

NCT05277597 · Healthy Males

Functionality of an 8-Channel Paddle Coil for Use With MRI

NCT02190344 · Prostate in Healthy Males

Increasing Ferulic Acid Bioavailability in Bran

NCT00777543 · Healthy Males

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 12, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment15

Start dateOct 2002

Last updatedApr 12, 2023

Condition

Locations shown

Progenics Pharmaceuticals, Inc.

Tarrytown, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions